标题
Clinical trials of human papillomavirus vaccines and beyond
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 10, Issue 7, Pages 400-410
出版商
Springer Nature
发表日期
2013-06-04
DOI
10.1038/nrclinonc.2013.84
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- Comparing the performance of six human papillomavirus tests in a screening population
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
- (2013) Amy Leval et al. JNCI-Journal of the National Cancer Institute
- HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
- (2013) Shih-Wen Lin et al. PLoS One
- High-Throughput Monitoring of Human Papillomavirus Type Distribution
- (2012) A. Soderlund-Strand et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination
- (2012) Johanna Palmroth et al. INTERNATIONAL JOURNAL OF CANCER
- Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer
- (2012) Gordana Halec et al. INTERNATIONAL JOURNAL OF CANCER
- Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up
- (2012) Muhammad Mohsin Rana et al. INTERNATIONAL JOURNAL OF CANCER
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Updating the Natural History of Human Papillomavirus and Anogenital Cancers
- (2012) Anna-Barbara Moscicki et al. VACCINE
- Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark
- (2012) B. Pasternak et al. BMJ-British Medical Journal
- Evaluation of the HPV 18 antibody response in Gardasil®vaccinees after 48 mo using a pseudovirion neutralization assay
- (2012) Christine Roberts et al. Human Vaccines & Immunotherapeutics
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
- (2011) A. Szarewski et al. INTERNATIONAL JOURNAL OF CANCER
- Clustering of Multiple Human Papillomavirus Infections in Women From a Population-Based Study in Guanacaste, Costa Rica
- (2011) Salvatore Vaccarella et al. JOURNAL OF INFECTIOUS DISEASES
- Clustering of Human Papillomavirus (HPV) Types in the Male Genital Tract: The HPV in Men (HIM) Study
- (2011) Salvatore Vaccarella et al. JOURNAL OF INFECTIOUS DISEASES
- Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
- (2011) C. Chao et al. JOURNAL OF INTERNAL MEDICINE
- Just implementation of human papillomavirus vaccination
- (2011) Erik Malmqvist et al. JOURNAL OF MEDICAL ETHICS
- Addressing the vaccine confidence gap
- (2011) Heidi J Larson et al. LANCET
- Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda
- (2011) Maria J Wawer et al. LANCET
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
- (2011) M. Lehtinen et al. SEXUALLY TRANSMITTED INFECTIONS
- Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
- (2011) Eve Draper et al. VACCINE
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
- (2010) H. Trottier et al. CANCER RESEARCH
- Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33
- (2010) Marko Merikukka et al. INTERNATIONAL JOURNAL OF CANCER
- Judging the carcinogenicity of human papillomavirus types by single/multiple infection ratio in cervical cancer
- (2010) Gary M. Clifford et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women
- (2010) Tiina Petäjä et al. INTERNATIONAL JOURNAL OF CANCER
- Coverage and Compliance of Human Papillomavirus Vaccines in Paris: Demonstration of Low Compliance With Non-School-Based Approaches
- (2010) Roman Rouzier et al. JOURNAL OF ADOLESCENT HEALTH
- Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men
- (2010) Timothy Wilkin et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- IL-4 directs both CD4 and CD8 T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo
- (2010) Karine Serre et al. MOLECULAR IMMUNOLOGY
- Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine
- (2010) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008
- (2010) La'Shan D. Taylor et al. PREVENTIVE MEDICINE
- Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes
- (2010) Johanna Palmroth et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women
- (2010) Proscovia Bazanya Namujju et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Cancers attributable to human papillomavirus infection
- (2010) Andrew E. Grulich et al. Sexual Health
- Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
- (2010) Joseph G. Dauner et al. VACCINE
- HPV - immune response to infection and vaccination
- (2010) Margaret Stanley Infectious Agents and Cancer
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Prospects for new human papillomavirus vaccines
- (2009) Margaret Stanley CURRENT OPINION IN INFECTIOUS DISEASES
- Impact of human papillomavirus vaccination depends on effective vaccination strategy
- (2009) Matti Lehtinen et al. INTERNATIONAL JOURNAL OF CANCER
- Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women
- (2009) Marjo Kaasila et al. INTERNATIONAL JOURNAL OF CANCER
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
- (2009) Anders Näsman et al. INTERNATIONAL JOURNAL OF CANCER
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
- Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
- (2008) A. S. Kapeu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination
- (2008) Helen Trottier et al. JOURNAL OF INFECTIOUS DISEASES
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
- (2008) Aline Simen-Kapeu et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
- (2008) Elmar A. Joura et al. VACCINE
- Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study
- (2008) Loretta Brabin et al. BMJ-British Medical Journal
- Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines
- (2007) Cosette M. Wheeler et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started